Skip to main content
. 2023 Jan 25;2023(1):CD014962. doi: 10.1002/14651858.CD014962.pub2

1.6. Analysis.

1.6

Comparison 1: Remdesivir and standard care versus standard care (plus/minus placebo) in moderate to severe COVID‐19, Outcome 6: Clinical improvement: alive and ready to discharge (time‐to‐event)